Mapi Pharma raised €8.8M in a funding round in Nov 2018. The company is based in Ness Ziona, Israel. Investors in the round: Shavit Capital. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
